Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

First case of new BQ.1 variant found in Thailand

The first case of Omicron's highly contagious variant BQ.1 has been detected in Thailand, according to the Centre for Medical Genomics at Ramathibodi Hospital.

Bangkok Post

First case of highly infectious BQ.1 variant found in Thailand

The first case of Omicron's highly transmissible and immune-evasive descendant called BQ.1 has been detected in Thailand, according to the Centre for Medical Genomics at Ramathibodi Hospital.

Bangkok Post

Pill Testers Discover A Type Of Ket That’s Only In Canberra Is It As Toxic As Living There?

Canberramine. Ketberra.

Pedestrian.tv

From analysis to the latest developments in health,
read the most diverse news in one place.

A new wave of COVID-19 cases may hit Texas this winter, infectious disease doctor says

DALLAS — Although COVID-19 is presently at one of its lowest rates in the Lone Star State, one Texas-based vaccine scientist is wary of what’s to come this winter.

Tribune News Service

How to spot the difference between colds, flu and Covid with key symptoms

Experts fear the UK is in the middle of a fourth wave of Covid and with the winter fast approaching, an increase in respiratory illnesses is also on the horizon

Daily Mirror

Is the zero-Covid policy in China worth the cost?

Before Covid-19 vaccines were developed and distributed, China's strict approach to controlling the virus resulted in fewer deaths and a much lower death rate per million people than in many other countries. But while these successes were impressive in late 2020 and early 2021, effective vaccines and treatments have become…

Bangkok Post

Pest control warning as super-rats resistant to B&Q killer chemicals are booming

Rats in Scotland are "learning to evade control measures", one pest expert has said.

Daily Record

Read news from The Economist, FT, and more,
with one subscription

2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

StockNews.com

Lab 'playing with fire' after creating new hybrid Covid strain 'with 80% kill rate'

Boston University scientists combined Omicron with the original Wuhan Covid strain to make a hybrid which killed 80% of the mice it was tested on, as experts warn such research needs better accountability

Daily Mirror

U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak

The United States sent Gilead Sciences' remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to an outbreak that has infected 60 people and killed 44, U.S. government sources told Reuters.

Reuters

Australia's first fixed pill testing service CanTEST discovers new drug, dubbed 'CanKet'

Australia's first fixed pill testing site has discovered a new recreational drug, similar to ketamine, not seen in the country before.

ABC News

New Drugs Approvals Bring No Relief for Ailing Innovent Bio

Key Takeaways: Innovent Bio has brought several drugs to market in recent years, including two announced last week, but is still losing money with no profits in sight The company has overhauled its commercialization model and is doing more licensing partnerships with multinationals to expand its drug pipeline By Molly…

Benzinga

Boston University COVID researchers combine omicron spike protein with original virus, test strain on mice

BOSTON — Boston University COVID researchers have combined the omicron variant spike protein with the original virus, testing the created strain on mice “to help fight against future pandemics,” according to BU.

Boston Herald

Pill-testing scientists uncover new drug

Canberra scientists have located a ketamine-like substance, in what could be the first time the new recreational drug has been discovered.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Philadelphia Inquirer

‘Rainbow fentanyl’ panic is obscuring the real dangers of a contaminated drug supply, experts say

PHILADELPHIA — As Halloween approaches, the federal government has been warning parents of a spooky new danger: Drug cartels are using rainbow-colored pills and powders that look like candy to introduce children to highly addictive synthetic opioids. One taste could kill.

The Guardian - AU

‘Canberra ketamine’: new recreational drug discovered at Australian pill-testing service

‘As far as we’re aware, this is the first detection of a new drug by a drug-checking service anywhere in the world,’ says professor

Wales Online

Menopause doctors debunk myths about HRT amid shortage

The treatment can help combat the unpleasant and often debilitating symptoms associated with the menopause, but right now there is a shortage

Belfast Live

GP on the latest bugs spreading across Northern Ireland and what symptoms to look out for

Winter diseases like colds, coughs and stomach bugs are on the rise

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

Slate of COVID variants could drive winter surge

XBB, another mutated version of Omicron, may be best suited to evade immune protections.

Daily Mirror

Holland & Barrett launches new menopause range and offers free advice in stores

Holland & Barrett has launched a new peri and menopause range for women going through the menopause, and are also offering free consultations with trained professionals

The Canberra Times

New drug detected at ACT fixed pill testing site

The drug is a ketamine-like substance.

Benzinga

Small Pharma's Q2 2023 Financial Results, 'Ultra Short-Acting Psychedelic Program' Underway

Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022. For the period numbers show:

Wales Online

Covid autumn booster jab - who is eligible, how has it changed and where to get one

As coronavirus cases soar once again many people are wanting to boost their immunity to the virus

The Times of India

IIT Delhi led researchers develop VLP-based vaccine candidate against COVID

Researchers at IIT Delhi in collaboration with the Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana have developed SARS-CoV-2 Virus-Like Particles (VLPs), which are a possible vaccine candidate, an official statement from the institute said.

Evening Standard

Ebola: What measures is Uganda taking to fight the outbreak?

A lockdown has been announced in Mubende and Kassanda

1 … 117 118 119 120

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

915 stories

Eli Lilly

749 stories

Australian National University

Vertex Pharmaceuticals Incorporated

65 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.